Medically Reviewed by Dr. Shradha Chakhaiyar, MBBS, DGO, MRCOG (London) — IVF Specialist & Reproductive Surgeon, Shradha IVF & Maternity, Patna
Quick Answer: No. Gender selection through IVF is illegal in India for non-medical reasons. The Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994 and the Assisted Reproductive Technology (Regulation) Act, 2021 prohibit choosing, testing for, or disclosing an embryo’s or fetus’s sex. The only legal exception is screening to prevent serious sex-linked genetic disorders, with documented medical justification.
Many couples exploring fertility treatment arrive with a sensitive and often misunderstood question: Can IVF be used to choose whether they have a boy or a girl? It is an understandable question — but in India, the answer is clear, and it matters that it is answered honestly. This guide explains exactly what the law says, how IVF actually works, what genetic testing is genuinely used for, and the one narrow medical exception that exists.
Can IVF Let You Choose a Boy or Girl Baby?
In India, the answer is no — IVF cannot lawfully be used to choose your baby’s sex. IVF (in vitro fertilisation) is an infertility treatment. It helps a couple conceive when natural conception is difficult; it is not a method for selecting the characteristics of a child. While the laboratory techniques used in IVF can, in theory, reveal an embryo’s chromosomal sex, Indian law strictly prohibits using that information to select an embryo by sex or disclosing the sex to the parents for any non-medical reason.
This is not a clinic policy or a matter of preference — it is the law, and it applies to every fertility clinic in the country. Any clinic that offers or promises gender selection is acting illegally.
How Is a Baby’s Gender Determined?
A baby’s sex is determined at the moment of fertilisation by the father’s sperm. Every egg carries an X chromosome. Sperm carry either an X or a Y chromosome.
- If an X-bearing sperm fertilises the egg → XX → a girl
- If a Y-bearing sperm fertilises the egg → XY → a boy
This happens naturally and randomly. No lawful fertility technique in India controls which sperm fertilises the egg, and no diet, timing, position, or “natural method” reliably influences it. Sex is decided by chance at conception.
IVF and Gender Selection: Understanding the Difference
It helps to understand what IVF actually involves, so it’s clear why “choosing gender” is a separate — and prohibited — act. A standard IVF cycle has five broad stages:
- Ovarian stimulation — medication helps the ovaries produce multiple eggs.
- Egg retrieval — the mature eggs are collected.
- Fertilisation — eggs and sperm are combined in the lab (sometimes using ICSI, where a single sperm is injected into each egg).
- Embryo culture — the fertilised eggs develop into embryos over a few days.
- Embryo transfer — a healthy embryo is placed into the uterus.
At no point in this process — when performed lawfully — is an embryo chosen based on sex. Genetic testing may be used to check an embryo’s health (more on this below), but using it to select or reveal sex for personal preference is illegal.
Can IVF Technology Identify Boy or Girl before Delivery?
Certain genetic tests performed during IVF can detect chromosomal patterns. However:
- Clinics in India cannot disclose embryo sex.
- Embryo selection cannot be based on gender.
- Reports must focus only on medically relevant findings.
What about sperm sorting?
Techniques such as sperm sorting claim to increase the probability of conceiving a specific sex. In India:
- these methods are not legally permitted for gender selection
- their marketing for sex selection is prohibited
- any such offer is a warning sign
Is Gender Selection Legal in India?
No. Non-medical sex selection is illegal in India, both before and after conception. Two laws govern this, and together they close every route to choosing a baby’s sex for personal or social reasons.
The PCPNDT Act, 1994
The Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act was enacted in 1994 and commenced on 1 January 1996. It was amended in 2003 to explicitly include pre-conception sex selection (which is why it is sometimes written PC-PNDT). The Act prohibits:
- Sex selection before or after conception
- Prenatal sex determination
- Disclosure of the sex of a fetus or embryo
- Advertising of sex-determination or sex-selection services
The ART (Regulation) Act, 2021
The Assisted Reproductive Technology (Regulation) Act, 2021 regulates fertility clinics and gamete banks and reinforces these prohibitions specifically within IVF. It bans:
- Separation of X and Y sperm for the purpose of sex selection
- Testing embryos for the purpose of sex selection
- Promotion or advertisement of gender-selection services
Clinics must maintain detailed records, register with the regulatory authority, and comply with inspection. Together, these two Acts mean that any clinic in India promising a baby of a chosen sex is acting illegally — a point we return to in the red-flags section below.
Legal vs Illegal Uses of Genetic Testing in IVF (India)
The nuance that confuses many couples is that genetic testing itself is not banned — it is widely used and medically valuable. What is banned is using it to choose or reveal sex for non-medical reasons. Here’s the clean distinction:
| Use of genetic testing in IVF | Legal in India? | Why |
|---|---|---|
| PGT-M to prevent a serious sex-linked disorder (e.g. Duchenne muscular dystrophy, haemophilia) | ✅ Legal | Medical justification; prevents transmission of serious disease |
| PGT-A to screen embryos for chromosomal normality | ✅ Legal | Improves success; sex is neither selected nor disclosed |
| Choosing an embryo’s sex for “family balancing” | ❌ Illegal | Non-medical sex selection — PCPNDT + ART Act |
| Sperm sorting to conceive a chosen sex | ❌ Illegal | Pre-conception sex selection |
| Disclosing the sex of an embryo or fetus | ❌ Illegal | Prohibited disclosure — PCPNDT Act |
| Advertising sex-selection services | ❌ Illegal | Prohibited advertising — PCPNDT Act |
What Is the Punishment for Sex Selection in India?
The penalties under the PCPNDT Act are deliberately serious, and they apply to clinics, doctors, and in some circumstances the people seeking the service:
- First offence: imprisonment of up to 3 years and a fine of up to ₹10,000.
- Subsequent offences: imprisonment of up to 5 years and a fine of up to ₹50,000.
- For doctors: on a complaint being made, the qualified medical practitioner’s name can be reported to the State Medical Council, which may suspend registration during proceedings and remove the name from the register on conviction — effectively ending the ability to practise.
The ART (Regulation) Act adds its own penalties for clinics that breach its provisions, including significant fines for sex selection. (Exact figures should be confirmed against the current text of each Act, as amendments and state-level implementation can vary.)
Is Sperm Sorting Legal in India?
No. Techniques such as sperm sorting claim to increase the probability of conceiving a specific sex by separating X-bearing and Y-bearing sperm. In India, this counts as pre-conception sex selection and is prohibited under both the PCPNDT Act (as amended in 2003) and the ART Act. Marketing sperm sorting for sex selection is also illegal. Any clinic offering it for “family balancing” is a warning sign.
When Is Embryo Sex Testing Legal in India?
There is one narrow, important exception. Indian law permits genetic testing that reveals chromosomal sex only when the purpose is to detect or prevent a serious sex-linked genetic disorder — never for social preference. Some serious inherited conditions are carried on the sex chromosomes and affect one sex far more severely than the other. Examples include:
- Duchenne muscular dystrophy — a progressive, life-limiting muscle-wasting disease that primarily affects boys
- Haemophilia A and B — bleeding disorders that primarily affect boys
In these specific cases, PGT-M (Preimplantation Genetic Testing for Monogenic disorders) may be used to avoid transmitting the condition — and this requires clear medical justification, documentation, and regulatory compliance. This is fundamentally different from choosing sex for personal preference: the goal is preventing serious disease, not selecting a boy or a girl. This medical exception exists in most countries that otherwise restrict sex selection.
Global Context: Why Some Countries Differ
In certain countries, gender selection may be permitted under restricted circumstances, such as preventing sex-linked genetic diseases. However, many nations restrict non-medical gender selection due to ethical and societal concerns.
India maintains strict prohibition to promote gender equality and prevent misuse of technology.
Genetic Testing in IVF: What It Is Actually Used For
Preimplantation Genetic Testing (PGT) is a legitimate, valuable part of modern IVF — used to improve success and prevent serious disease, never for sex selection. There are three main types:
- PGT-A (for Aneuploidies) — checks whether an embryo has the correct number of chromosomes. This improves implantation rates and reduces miscarriage, and is particularly useful for older women or after repeated failure. (Our guide on why a perfect embryo fails in IVF explains PGT-A in more depth.)
- PGT-M (for Monogenic disorders) — tests for specific inherited single-gene conditions such as thalassemia, sickle cell disease, cystic fibrosis, and the sex-linked disorders described above.
- PGT-SR (for Structural Rearrangements) — detects structural chromosomal problems such as translocations.
It is important to understand that while genetic testing can reveal chromosomal sex, using this information for non-medical gender selection is illegal in India. Its purpose is disease prevention and improved reproductive outcomes.
Genetic testing does not guarantee pregnancy success, but it can enhance embryo selection accuracy in certain clinical situations, particularly for older patients, recurrent miscarriages, or known genetic risks.
By focusing on health and genetic integrity, PGT supports the ultimate goal of IVF: a healthy pregnancy and baby.
Ethical and Medical Considerations while Tempting to Reveal Gender in India
- The ethical framework surrounding assisted reproductive technology is grounded in respect for human life, equality, and responsible medical practice. Gender selection for non-medical reasons raises significant ethical concerns because it reinforces gender bias and social inequality.
- In societies where gender preference exists, unrestricted selection could distort demographic balance and perpetuate discrimination. Laws prohibiting non-medical sex selection aim to prevent these societal harms and uphold gender equity.
- From a medical perspective, fertility treatment should prioritize health outcomes. Embryo selection is performed to improve implantation potential and reduce genetic disease risk — not to fulfill social preferences.
- Ethically responsible care also requires balancing patient autonomy with societal responsibility. While patients may express personal preferences, clinicians must adhere to legal standards and ethical obligations.
- There are also medical risks associated with unnecessary embryo manipulation. Procedures performed without a clear medical indication may expose embryos to additional handling without health benefits.
- Furthermore, ethical fertility practice emphasizes informed decision-making. Patients should receive accurate information about what procedures can and cannot achieve, along with legal and moral implications.
- Respecting ethical boundaries protects patients, future children, and society. When fertility care aligns with ethical principles, it reinforces trust in reproductive medicine and safeguards long-term social wellbeing.
Common Myths About IVF and Gender Reveal During Pregnancy in India
Misconceptions about IVF often spread through social media, anecdotal experiences, or cultural beliefs. Clearing these myths helps couples make decisions based on science rather than misinformation.
One widespread myth is that IVF allows couples to choose a baby’s gender. In reality, gender selection for non-medical purposes is prohibited in India. IVF’s primary objective is to assist conception, not to determine personal traits.
Another misconception is that certain timing methods or diets can influence embryo gender during IVF. Scientific evidence does not support claims that nutrition, timing, or sexual positions influence embryo sex.
Some believe that IVF naturally increases the likelihood of having a boy or girl. In fact, IVF does not intentionally bias gender outcomes. Slight variations seen in some studies are related to embryo development dynamics and transfer timing, not deliberate selection.
A common myth suggests genetic testing is done to select gender. In truth, preimplantation genetic testing (PGT) is used to detect chromosomal abnormalities or inherited diseases. Any gender information revealed during testing cannot legally be used for non-medical selection.
Another misconception is that choosing gender improves family happiness or balance. Research consistently shows that parental bonding and child wellbeing depend on nurturing environments, not gender.
Understanding these myths empowers couples to approach fertility care with realistic expectations and reduces vulnerability to misleading claims.
Red Flags while trying to Know Gender in India: When to Be Cautious
During fertility treatment planning, I encourage couples to stay alert to practices that may signal unethical or non-compliant care. Awareness helps prevent emotional distress, financial loss, and legal complications.
A major red flag is any clinic that promises gender selection for non-medical reasons. In India, revealing or selecting fetal sex without medical justification is illegal. Marketing language that hints at “family balancing” or guarantees gender outcomes should be treated with caution.
Another warning sign is a lack of transparency in treatment plans and pricing. Ethical clinics clearly explain what is medically necessary, what is optional, and what additional procedures cost. Hidden fees or pressure to add unnecessary procedures may indicate profit-driven rather than patient-centered care.
Be cautious if success rates are advertised without context. IVF outcomes depend on age, diagnosis, and embryo quality. Claims such as “guaranteed pregnancy” or “100% success” are scientifically unrealistic and ethically questionable.
Poor documentation and inadequate consent processes are also concerning. Patients should receive clear written consent forms explaining procedures such as ICSI, embryo freezing, or genetic testing. Informed consent is a fundamental component of ethical medical practice.
Another indicator is the absence of counselling. Responsible clinics provide counselling about emotional impact, multiple pregnancy risks, and alternative options. Fertility care should support holistic wellbeing, not just procedural intervention.
Lastly, verify accreditation and regulatory compliance. Clinics should adhere to national guidelines and ethical standards governing assisted reproductive technology. When a clinic prioritizes safety, transparency, and compliance, patients can proceed with greater trust.
What Couples Should Focus On Instead of Knowing About Gender During IVF Treatment?
When I speak with couples exploring IVF, I often notice that anxiety about outcomes overshadows the more important goal: achieving a healthy pregnancy and safe delivery. Instead of focusing on gender, it is far more productive to concentrate on factors that genuinely influence success and maternal well-being.
First, embryo health and chromosomal normalcy are critical predictors of implantation and miscarriage risk. A chromosomally normal embryo has a significantly higher chance of leading to a healthy pregnancy compared to an abnormal embryo. This is why clinics emphasize embryo grading, laboratory quality, and culture conditions rather than non-medical traits.
Second, maternal health plays a decisive role. Optimizing thyroid levels, managing insulin resistance, maintaining a healthy BMI, correcting vitamin deficiencies, and addressing uterine conditions such as fibroids or polyps can meaningfully improve outcomes. Even small lifestyle changes — adequate sleep, balanced nutrition, reducing alcohol intake, and quitting smoking — contribute to reproductive health.
Third, the clinic’s laboratory standards and expertise matter. IVF success is not just about technology but about embryologists’ skill, air quality systems, temperature stability, and stringent protocols that protect embryos during development.
Fourth, emotional readiness deserves attention. Fertility treatment can be physically and psychologically demanding. Couples who prioritize mental health support, counselling, and stress management often navigate the journey with greater resilience.
Finally, understanding realistic expectations is essential. IVF is a treatment, not a guarantee. Age, ovarian reserve, sperm health, and underlying medical conditions all influence success rates. Focusing on controllable health factors and selecting a transparent clinic builds confidence and clarity.
Shifting attention from gender preference to evidence-based success factors allows couples to make informed decisions rooted in health, safety, and long-term wellbeing.
A Positive Mindset Toward Parenthood
Every child deserves equal love and opportunity. IVF is about creating families and fulfilling the dream of parenthood — not choosing traits.
Parents who embrace this perspective experience a more meaningful and emotionally healthy journey into parenthood.
Final Thoughts
Gender selection through IVF is illegal in India and ethically discouraged. While reproductive science continues to advance, the focus of fertility treatment remains on achieving healthy pregnancies and protecting societal balance.
Understanding the law, the science, and the ethical responsibilities surrounding IVF empowers couples to make informed, respectful decisions on their path to parenthood.
About Shradha IVF & Maternity
For couples navigating fertility treatment, clarity, trust, and ethical care are essential. Shradha IVF & Maternity in Patna has become a trusted destination for families across Bihar and eastern India seeking advanced fertility care grounded in compassion and transparency.
At Shradha IVF, patient education is a cornerstone of care. Many couples arrive with questions about gender selection, genetic testing, and legal guidelines. The clinic provides clear counseling on Indian laws, ethical fertility practices, and medically appropriate treatment options. Patients receive honest guidance so they can make informed decisions without confusion or misinformation.
The center follows evidence-based IVF protocols designed to maximize success while prioritizing safety and affordability. Genetic testing is offered only when medically indicated and always within legal guidelines. The clinic maintains strict compliance with national regulations, ensuring that embryo sex disclosure or selection is never practiced.
Shradha IVF’s advanced embryology laboratory supports high-quality embryo culture and monitoring, helping improve success rates while minimizing the need for repeated cycles. Personalized stimulation protocols help avoid unnecessary medication costs and reduce treatment burden.
Beyond technology, the clinic emphasizes patient-centered care. Couples benefit from bilingual support, individualized treatment planning, and compassionate counseling throughout their journey. Emotional well-being is considered just as important as medical success.
Financial transparency is another key strength. Clear cost explanations, structured payment guidance, and ethical treatment recommendations help families plan confidently without hidden surprises.
Shradha IVF also coordinates genetic counseling and comprehensive diagnostics when needed, ensuring that treatment decisions prioritize healthy pregnancy outcomes rather than unnecessary procedures.
For families facing infertility challenges, the clinic’s mission is simple: provide ethical, lawful, and compassionate fertility care that helps create healthy families while respecting medical integrity and social responsibility.
By combining advanced reproductive science with patient education and empathy, Shradha IVF & Maternity supports couples not only in achieving pregnancy but in beginning parenthood with confidence, clarity, and peace of mind.
FAQs on Gender Selection in India
No. Gender selection through IVF is illegal in India for non-medical reasons. The PCPNDT Act (1994) and the ART Act (2021) strictly prohibit selecting, testing for, or revealing the sex of an embryo or fetus for personal or social preference. The only exception is preventing serious sex-linked genetic disorders.
Two laws: the Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act, 1994 (amended 2003) and the Assisted Reproductive Technology (Regulation) Act, 2021. Together they ban sex selection before and after conception, sperm sorting for sex, embryo sex testing for selection, sex disclosure, and advertising of such services.
Genetic testing such as PGT can technically identify chromosomal sex, but doctors in India are legally prohibited from disclosing this information or using it for sex selection. Reports must focus only on medically relevant findings. Disclosing embryo or fetal sex is a criminal offence under the PCPNDT Act.
Under the PCPNDT Act, a first offence carries up to 3 years imprisonment and a fine up to ₹10,000; subsequent offences up to 5 years and ₹50,000. A convicted doctor's name can be removed from the State Medical Register, ending their ability to practise. The ART Act adds further penalties.
Preimplantation genetic testing (PGT) is used to detect chromosomal abnormalities (PGT-A), prevent inherited monogenic diseases like thalassemia or sickle cell (PGT-M), and identify structural chromosomal rearrangements (PGT-SR). Its purpose is improving pregnancy success and preventing serious genetic disease — never non-medical sex selection.
No. IVF does not intentionally bias gender outcomes. Some studies show very slight variations linked to embryo development and transfer timing, not deliberate selection. The sex is still determined by whether an X-bearing or Y-bearing sperm fertilised the egg — which IVF does not control in lawful practice.

